Now Available: Journey Medical’s Emrosi for Rosacea
Journey Medical Corporation’s Emrosi (40mg Minocycline Hydrochloride Modified-Release Capsules, 10mg immediate release and 30mg extended release) is now available for the treatment of inflammatory lesions of rosacea in adults by prescription at specialty pharmacy chains. The U.S. Food and Drug Administration approved Emrosi for the treatment of inflammatory lesions of rosacea in adults in November […]